Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 4.13 | 0.35 | 5.87 |
| 6M | 1.06 | 1.58 | 8.72 |
| 1Y | 6.54 | 4.97 | 15.27 |
| 3Y | 22.86 | 16.66 | 113.85 |
Tata India Pharma & HealthCare Fund Growth managed by Tata Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,325 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.21. Under the expert guidance of Rajat Srivastava ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Rajat Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad. Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| Nippon India Pharma Fund Growth | 4 | 8365.4 CR | 2.32 |
| LIC MF Healthcare Fund Growth | 1 | 84.53 CR | 2.44 |
| Tata India Pharma & HealthCare Fund Growth | 2 | 1325.19 CR | 2.21 |
| UTI Healthcare Fund Growth | 3 | 1143.58 CR | 2.3 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 5 | 6668.95 CR | 2.41 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundNippon India Pharma Fund Growth | 5.3886 | 85.2065 |
| This FundLIC MF Healthcare Fund Growth | 8.5855 | 85.4289 |
| This FundTata India Pharma & HealthCare Fund Growth | 6.544 | 85.47 |
| This FundUTI Healthcare Fund Growth | 10.7578 | 103.6121 |
| This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 6.8645 | 108.6146 |